+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Plasmid DNA Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031

  • PDF Icon

    Report

  • 119 Pages
  • January 2024
  • Region: Global
  • Acute Market Reports
  • ID: 5932803
Description Jump to:
The plasmid DNA manufacturing market is characterized by its critical role in the production of plasmid DNA used in various therapeutic applications. The plasmid DNA manufacturing market is expected to grow at a CAGR of 21% during the forecast period of 2024 to 2032. The ongoing drivers and innovative strategies employed by key players are expected to shape the landscape of plasmid DNA manufacturing, contributing to the development of advanced genetic therapies and personalized medicine solutions.

Advancements in Genetic Therapies: Pioneering Innovations in Plasmid DNA Applications

The plasmid DNA manufacturing market is being propelled by continuous advancements in genetic therapies, exemplified by pioneering innovations in plasmid DNA applications. Evidence includes the successful integration of plasmid DNA in cutting-edge gene therapies targeting various genetic disorders and chronic diseases. This driver is underscored by the expanding landscape of gene-based therapeutics, with plasmid DNA serving as a crucial component in developing novel treatments. As evidenced by the growing number of clinical trials and approvals for plasmid DNA-based therapies, this driver is expected to be a primary contributor to the market's growth from 2023 to 2032.

Increasing Investments in Biopharmaceutical R&D: Fueling Demand for High-Quality Plasmid DNA

The plasmid DNA manufacturing market is experiencing robust growth due to increasing investments in biopharmaceutical research and development (R&D). Evidence includes rising funding and collaborations in the biopharmaceutical sector, leading to a surge in demand for high-quality plasmid DNA for pre-clinical and clinical studies. This driver is emphasized by the pivotal role of plasmid DNA in the development of gene therapies, vaccines, and other biopharmaceutical products. As evidenced by the substantial increase in R&D activities and partnerships, the market is poised to benefit significantly from the sustained investment in biopharmaceutical innovations.

Growing Emphasis on Personalized Medicine: Customized Plasmid DNA Solutions for Targeted Therapies

The plasmid DNA manufacturing market is witnessing a paradigm shift driven by the growing emphasis on personalized medicine. Evidence includes the increased focus on tailoring therapeutic interventions to individual patient profiles, necessitating the production of customized plasmid DNA solutions. This driver is highlighted by the expanding applications of plasmid DNA in precision medicine, enabling the development of targeted therapies with enhanced efficacy and safety profiles. As evidenced by the rising interest in personalized medicine approaches, the demand for plasmid DNA manufacturing is expected to surge, catering to the specific requirements of individualized treatment strategies.

Regulatory Challenges and Compliance: Navigating Complex Regulatory Landscape

A significant restraint in the plasmid DNA manufacturing market revolves around regulatory challenges and compliance issues. Evidences include the stringent regulations governing the production and quality control of plasmid DNA for therapeutic use. This restraint is further underscored by the need for manufacturers to navigate a complex regulatory landscape, ensuring adherence to guidelines set by regulatory authorities. The evidence also includes instances where regulatory uncertainties and evolving compliance standards pose challenges to market players, impacting the pace of product development and market penetration. Overcoming this restraint requires a proactive approach to establishing robust quality management systems and staying abreast of evolving regulatory requirements.

By Grade: Plasmid DNA Manufacturing Market Dominates the Market

In 2023, the plasmid DNA manufacturing market demonstrated substantial revenue from the GMP Grade segment, reflecting the demand for plasmid DNA meeting stringent Good Manufacturing Practice standards. Simultaneously, the highest CAGR during the forecast period from 2024 to 2032 was observed in the R&D Grade segment, indicating a robust focus on research activities requiring high-quality plasmid DNA. This nuanced segmentation reflects the diverse applications of plasmid DNA across different grades, each catering to specific industry requirements and quality standards.

By Development Phase: Plasmid DNA Manufacturing Market Dominates the Market

The plasmid DNA manufacturing market showcased noteworthy revenue from the Clinical Therapeutics segment in 2023, emphasizing the pivotal role of plasmid DNA in advancing clinical-stage therapies. Concurrently, the highest CAGR during the forecast period was recorded in the Pre-Clinical Therapeutics segment, signifying a surge in research and development activities. This comprehensive segmentation illustrates the dynamic nature of plasmid DNA applications across different development phases, with each phase contributing uniquely to the market's overall growth.

North America Remains the Global Leader

Geographically, the plasmid DNA manufacturing market exhibited diverse trends in 2023, with North America leading in revenue generation and the highest CAGR. This reflects the region's dominance in biopharmaceutical R&D and its role as a hub for innovative gene therapy initiatives. Europe also contributed significantly to revenue, driven by a robust biotechnology landscape and increasing investments in personalized medicine. Asia-Pacific, while emerging, maintained a steady demand for plasmid DNA manufacturing, fueled by growing collaborations and a rising focus on biopharmaceutical advancements. These geographic trends underscore the global nature of the plasmid DNA manufacturing market, with different regions playing crucial roles in its expansion and evolution.

Market Competition to Intensify during the Forecast Period

In the competitive landscape, top players such as Lonza Group, Fujifilm Holdings Corporation, Aldevron LLC, Charles River Laboratories, VGXI, Inc., Danaher (Aldevron), Kaneka Corp., Nature Technology, Cell and Gene Therapy Catapult, Eurofins Genomics, Luminous BioSciences, LLC and Akron Biotech are shaping the market with their extensive expertise and strategic approaches. These key players reported substantial revenues in 2023, with expectations of continued growth from 2024 to 2032. Their strategic focus on addressing the evolving needs of genetic therapies, expanding production capacities, and ensuring compliance with regulatory standards positions them as influential entities in the plasmid DNA manufacturing landscape. As the market progresses, these players are anticipated to play a pivotal role in advancing technologies and contributing to the seamless production of high-quality plasmid DNA for therapeutic applications.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Plasmid DNA Manufacturing market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generated by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Plasmid DNA Manufacturing market and their expected impact during the forecast period.
The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. The gowth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. The application of both top down and bottom-up approaches for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Grade

  • R&D Grade
  • GMP Grade

Development Phase

  • Pre-Clinical Therapeutics
  • Clinical Therapeutics
  • Marketed Therapeutics

Application

  • DNA Vaccines
  • Cell & Gene Therapy
  • Immunotherapy
  • Others

Disease

  • Infectious Disease
  • Cancer
  • Genetic Disorder
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key Questions Answered in This Report

  • What are the key micro and macro environmental factors that are impacting the growth of Plasmid DNA Manufacturing market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Plasmid DNA Manufacturing market?
  • Which is the largest regional market for Plasmid DNA Manufacturing market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Plasmid DNA Manufacturing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Plasmid DNA Manufacturing market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Plasmid DNA Manufacturing Market
2.2. Global Plasmid DNA Manufacturing Market, By Grade, 2023 (US$ Million)
2.3. Global Plasmid DNA Manufacturing Market, By Development Phase, 2023 (US$ Million)
2.4. Global Plasmid DNA Manufacturing Market, By Application, 2023 (US$ Million)
2.5. Global Plasmid DNA Manufacturing Market, By Disease, 2023 (US$ Million)
2.6. Global Plasmid DNA Manufacturing Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023
3. Plasmid DNA Manufacturing Market: Competitive Analysis
3.1. Market Positioning of Key Plasmid DNA Manufacturing Market Vendors
3.2. Strategies Adopted by Plasmid DNA Manufacturing Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Plasmid DNA Manufacturing Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Plasmid DNA Manufacturing Market Value, 2022-2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Volume and Pricing Analysis, 2022-2032
5.4. Market Segmentation
5.4.1. R&D Grade
5.4.2. GMP Grade
6. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Volume and Pricing Analysis, 2022-2032
6.4. Market Segmentation
6.4.1. Pre-Clinical Therapeutics
6.4.2. Clinical Therapeutics
6.4.3. Marketed Therapeutics
7. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Volume and Pricing Analysis, 2022-2032
7.4. Market Segmentation
7.4.1. DNA Vaccines
7.4.2. Cell & Gene Therapy
7.4.3. Immunotherapy
7.4.4. Others
8. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Volume and Pricing Analysis, 2022-2032
8.4. Market Segmentation
8.4.1. Infectious Disease
8.4.2. Cancer
8.4.3. Genetic Disorder
8.4.4. Others
9. North America Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
9.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
9.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
9.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
9.6. Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
9.6.1. North America
9.6.1.1. U.S.
9.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
9.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
9.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
9.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
9.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
9.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
9.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
9.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
9.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
9.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
10. UK and European Union Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
10.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
10.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
10.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
10.6. Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
10.6.1. UK and European Union
10.6.1.1. UK
10.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
10.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
10.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
10.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
10.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
10.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
10.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
10.6.1.4.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
10.6.1.4.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.4.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
10.6.1.5.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
10.6.1.5.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.5.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
10.6.1.6.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
10.6.1.6.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.6.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
11. Asia Pacific Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
11.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
11.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
11.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
11.6. Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
11.6.1. Asia Pacific
11.6.1.1. China
11.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
11.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
11.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
11.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
11.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
11.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
11.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
11.6.1.4.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
11.6.1.4.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.4.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
11.6.1.5.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
11.6.1.5.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.5.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
11.6.1.6.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
11.6.1.6.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.6.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
12. Latin America Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
12.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
12.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
12.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
12.6. Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
12.6.1. Latin America
12.6.1.1. Brazil
12.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
12.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
12.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
12.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
12.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
12.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
12.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
12.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
12.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
12.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
13. Middle East and Africa Plasmid DNA Manufacturing Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
13.3. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
13.4. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
13.5. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
13.6. Plasmid DNA Manufacturing Market: By Region, 2022-2032, USD (Million)
13.6.1. Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
13.6.1.1.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
13.6.1.1.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
13.6.1.1.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
13.6.1.2.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
13.6.1.2.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
13.6.1.2.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Plasmid DNA Manufacturing Market: By Grade, 2022-2032, USD (Million)
13.6.1.3.2. Plasmid DNA Manufacturing Market: By Development Phase, 2022-2032, USD (Million)
13.6.1.3.3. Plasmid DNA Manufacturing Market: By Application, 2022-2032, USD (Million)
13.6.1.3.4. Plasmid DNA Manufacturing Market: By Disease, 2022-2032, USD (Million)
14. Company Profiles
14.1. Lonza Group
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Fujifilm Holdings Corporation
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Aldevron LLC
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Charles River Laboratories
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. VGXI, Inc.
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Danaher (Aldevron)
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Kaneka Corp.
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Nature Technology
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Cell and Gene Therapy Catapult
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Eurofins Genomics
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Luminous BioSciences, LLC
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Akron Biotech
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Other Notable Players
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives
List of Figures
Figure 1 Global Plasmid DNA Manufacturing Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Plasmid DNA Manufacturing Market: Quality Assurance
Figure 5 Global Plasmid DNA Manufacturing Market, by Grade, 2023
Figure 6 Global Plasmid DNA Manufacturing Market, by Development Phase, 2023
Figure 7 Global Plasmid DNA Manufacturing Market, by Application, 2023
Figure 8 Global Plasmid DNA Manufacturing Market, by Disease, 2023
Figure 9 Global Plasmid DNA Manufacturing Market, by Geography, 2023
Figure 10 Market Geographical Opportunity Matrix - Global Plasmid DNA Manufacturing Market, 2023
Figure 11 Market Positioning of Key Plasmid DNA Manufacturing Market Players, 2023
Figure 12 Global Plasmid DNA Manufacturing Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
Figure 13 Global Plasmid DNA Manufacturing Market, by Grade, 2023 Vs 2032, %
Figure 14 Global Plasmid DNA Manufacturing Market, by Development Phase, 2023 Vs 2032, %
Figure 15 Global Plasmid DNA Manufacturing Market, by Application, 2023 Vs 2032, %
Figure 16 Global Plasmid DNA Manufacturing Market, by Disease, 2023 Vs 2032, %
Figure 17 U.S. Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 18 Canada Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 19 Rest of North America Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 20 UK Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 21 Germany Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 22 Spain Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 23 Italy Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 24 France Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 25 Rest of Europe Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 26 China Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 27 Japan Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 28 India Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 29 Australia Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 30 South Korea Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 31 Rest of Asia Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 32 Brazil Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 33 Mexico Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 34 Rest of Latin America Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 35 GCC Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 36 Africa Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
Figure 37 Rest of Middle East and Africa Plasmid DNA Manufacturing Market (US$ Million), 2022-2032
List of Tables
Table 1 Global Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 2 Global Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 3 Global Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 4 Global Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 5 North America Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 6 North America Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 7 North America Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 8 North America Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 9 U.S. Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 10 U.S. Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 11 U.S. Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 12 U.S. Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 13 Canada Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 14 Canada Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 15 Canada Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 16 Canada Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 17 Rest of North America Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 18 Rest of North America Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 19 Rest of North America Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 20 Rest of North America Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 21 UK and European Union Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 22 UK and European Union Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 23 UK and European Union Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 24 UK and European Union Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 25 UK Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 26 UK Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 27 UK Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 28 UK Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 29 Germany Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 30 Germany Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 31 Germany Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 32 Germany Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 33 Spain Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 34 Spain Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 35 Spain Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 36 Spain Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 37 Italy Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 38 Italy Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 39 Italy Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 40 Italy Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 41 France Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 42 France Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 43 France Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 44 France Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 45 Rest of Europe Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 46 Rest of Europe Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 47 Rest of Europe Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 48 Rest of Europe Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 49 Asia Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 50 Asia Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 51 Asia Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 52 Asia Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 53 China Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 54 China Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 55 China Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 56 China Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 57 Japan Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 58 Japan Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 59 Japan Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 60 Japan Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 61 India Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 62 India Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 63 India Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 64 India Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 65 Australia Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 66 Australia Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 67 Australia Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 68 Australia Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 69 South Korea Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 70 South Korea Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 71 South Korea Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 72 South Korea Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 73 Latin America Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 74 Latin America Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 75 Latin America Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 76 Latin America Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 77 Brazil Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 78 Brazil Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 79 Brazil Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 80 Brazil Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 81 Mexico Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 82 Mexico Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 83 Mexico Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 84 Mexico Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 85 Rest of Latin America Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 86 Rest of Latin America Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 87 Rest of Latin America Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 88 Rest of Latin America Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 89 Middle East and Africa Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 90 Middle East and Africa Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 91 Middle East and Africa Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 92 Middle East and Africa Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 93 GCC Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 94 GCC Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 95 GCC Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 96 GCC Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 97 Africa Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 98 Africa Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 99 Africa Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 100 Africa Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)
Table 101 Rest of Middle East and Africa Plasmid DNA Manufacturing Market by Grade, 2022-2032, USD (Million)
Table 102 Rest of Middle East and Africa Plasmid DNA Manufacturing Market by Development Phase, 2022-2032, USD (Million)
Table 103 Rest of Middle East and Africa Plasmid DNA Manufacturing Market by Application, 2022-2032, USD (Million)
Table 104 Rest of Middle East and Africa Plasmid DNA Manufacturing Market by Disease, 2022-2032, USD (Million)

Companies Mentioned

  • Lonza Group
  • Fujifilm Holdings Corporation
  • Aldevron LLC
  • Charles River Laboratories
  • VGXI, Inc.
  • Danaher (Aldevron)
  • Kaneka Corp.
  • Nature Technology
  • Cell and Gene Therapy Catapult
  • Eurofins Genomics
  • Luminous BioSciences, LLC
  • Akron Biotech

Related Topics

Related Reports

Global Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report by Disease (Cancer, Infectious Diseases), Grade (R&D Grade, GMP Grade), Application, Development Phase, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report by Disease (Cancer, Infectious Diseases), Grade (R&D Grade, GMP Grade), Application, Development Phase, Region, and Segment Forecasts, 2024-2030

  • Report
  • 110 Pages
  • Global
From
Viral Vectors and Plasmid DNA Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts- 2023 to 2031 - Product Image

Viral Vectors and Plasmid DNA Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts- 2023 to 2031

  • Report
  • 113 Pages
  • Global
From
Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028 - Product Image

Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028

  • Report
  • 317 Pages
  • Global
From
Plasmid DNA Manufacturing Market by Scale of Operation, Application Area, Therapeutic Area, and Geography: Industry Trends and Global Forecasts, 2023-2035 - Product Image

Plasmid DNA Manufacturing Market by Scale of Operation, Application Area, Therapeutic Area, and Geography: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • 255 Pages
  • Global
From
Global Viral Vector & Plasmid DNA Manufacturing Market by Type (Plasmid DNA, Viral Vector), Cell Line (In-vitro, In-Vivo), Transfection, Indication, Workflow, Application, End User - Forecast 2023-2030 - Product Image

Global Viral Vector & Plasmid DNA Manufacturing Market by Type (Plasmid DNA, Viral Vector), Cell Line (In-vitro, In-Vivo), Transfection, Indication, Workflow, Application, End User - Forecast 2023-2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.